These results confirm that RHEBL1 and RNPC3 may be potential targets for Polyphyllin VI and Protodioscin in the treatment of non-small cell lung cancer and may also be candidate diagnostic genes for determining the prognosis associated with non-small cell lung cancer. The gene discussed is RNPC3; the disease is non-small cell lung carcinoma.